ACADIA Pharmaceuticals Inc. (ACAD)

NASDAQ: ACAD · Real-Time Price · USD

27.83

+0.09 (0.32%)

At close: Sep 11, 2026, 4:00 PM EDT

27.55

-0.28 (-1.01%)

After-hours: Sep 11, 2026, 7:34 PM EDT

ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,795	4,519	3,053	5,140	2,578	3,752
Market Cap Growth	19.42%	48.00%	-40.60%	99.40%	-31.29%	-55.85%
Enterprise Value	3,913	3,727	2,537	4,852	2,204	3,278
Last Close Price	27.83	26.71	18.35	31.31	15.92	23.34

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.62	11.56	13.48	-	-	-
Forward PE	34.93	40.38	35.90	27.40	-	-
PS Ratio	4.21	4.22	3.19	7.08	4.98	7.75
PB Ratio	3.67	3.68	4.17	11.91	6.44	6.94
P/TBV Ratio	3.99	4.04	4.98	14.04	6.44	6.94
P/FCF Ratio	32.93	42.98	19.42	308.70	-	-
P/OCF Ratio	29.91	41.14	19.36	307.78	-	-
PEG Ratio	-	7.43	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.44	3.48	2.65	6.68	4.26	6.77
EV/EBITDA Ratio	39.77	31.97	25.33	-	-	-
EV/EBIT Ratio	45.30	35.56	30.11	-	-	-
EV/FCF Ratio	26.87	35.44	16.14	291.36	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.06	0.04	0.07	0.13	0.16	0.12
Debt / EBITDA Ratio	0.66	0.40	0.47	-	-	-
Debt / FCF Ratio	0.51	0.50	0.33	3.44	-	-
Net Debt / Equity Ratio	-0.68	-0.62	-0.96	-0.88	-0.89	-0.84
Net Debt / EBITDA Ratio	-8.97	-6.58	-7.03	5.63	1.60	2.73
Net Debt / FCF Ratio	-6.06	-7.30	-4.48	-22.92	3.11	3.60
Asset Turnover	0.77	0.78	0.99	1.09	0.80	0.65
Inventory Turnover	14.77	14.76	13.33	18.53	51.22	29.44
Quick Ratio	3.11	3.49	2.18	2.13	3.82	6.10
Current Ratio	3.39	3.83	2.38	2.42	4.04	6.43
Return on Equity (ROE)	35.74%	39.89%	38.89%	-14.73%	-45.89%	-28.75%
Return on Assets (ROA)	3.64%	4.76%	5.44%	-6.86%	-21.70%	-14.37%
Return on Invested Capital (ROIC)	19.82%	42.90%	187.48%	-153.38%	-343.44%	-263.80%
Return on Capital Employed (ROCE)	6.30%	8.10%	10.60%	-14.80%	-48.40%	-28.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	7.93%	8.65%	7.42%	-1.19%	-8.38%	-4.47%
FCF Yield	3.04%	2.33%	5.15%	0.32%	-4.42%	-3.38%
Buyback Yield / Dilution	-2.98%	-2.14%	-1.55%	-1.32%	-0.74%	-2.01%

SEC Filings: 10-K · 10-Q